Sak Katrin
NGO Praeventio, Tartu, Estonia E-mail :
Asian Pac J Cancer Prev. 2014;15(19):8007-19. doi: 10.7314/apjcp.2014.15.19.8007.
Cervical cancer is the most common gynecologic malignancy worldwide and development of new therapeutic strategies and anticancer agents is an urgent priority. Plants have remained an important source in the search for novel cytotoxic compounds and several polyphenolic flavonoids possess antitumor properties. In this review article, data about potential anticarcinogenic activity of common natural flavonoids on various human cervical cancer cell lines are compiled and analyzed showing perspectives for the use of these secondary metabolites in the treatment of cervical carcinoma as well as in the development of novel chemotherapeutic drugs. Such anticancer effects of flavonoids seem to differentially depend on the cellular type and origin of cervical carcinoma creating possibilities for specific targeting in the future. Besides the cytotoxic activity per se, several flavonoids can also contribute to the increase in efficacy of conventional therapies rendering tumor cells more sensitive to standard chemotherapeutics and irradiation. Although the current knowledge is still rather scarce and further studies are certainly needed, it is clear that natural flavonoids may have a great potential to benefit cervical cancer patients.
宫颈癌是全球最常见的妇科恶性肿瘤,开发新的治疗策略和抗癌药物是当务之急。植物一直是寻找新型细胞毒性化合物的重要来源,几种多酚类黄酮具有抗肿瘤特性。在这篇综述文章中,汇总并分析了常见天然黄酮对各种人宫颈癌细胞系潜在抗癌活性的数据,展示了这些次生代谢产物在宫颈癌治疗以及新型化疗药物开发中的应用前景。黄酮类化合物的这种抗癌作用似乎因宫颈癌细胞的类型和来源不同而有所差异,为未来的特异性靶向治疗创造了可能性。除了本身的细胞毒性活性外,几种黄酮类化合物还可以提高传统疗法的疗效,使肿瘤细胞对标准化疗和放疗更敏感。尽管目前的知识仍然相当匮乏,肯定还需要进一步研究,但很明显,天然黄酮类化合物可能对宫颈癌患者有很大益处。
Asian Pac J Cancer Prev. 2014
Anticancer Agents Med Chem. 2015
Biomed Pharmacother. 2017-7-29
Food Chem Toxicol. 2011-9-24
Int J Mol Sci. 2025-2-10